Zoltán G.
- Country
- Hungary
- Department
- Belgyógyászati Klinika, Klinikai Immunológiai Tanszék
Research Overview
- C0251006 - A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS)
- A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
- Evaluation of Efficacy, Safety, and Pharmacokinetics of Human Normal Immunoglobulin (IgPro20) in Adults with Dermatomyositis: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 92 of 193 partner sites.
Specializations
Inflammatory Myopathies
Specializes in the investigation of novel treatments for idiopathic inflammatory myopathy (IIM), with particular focus on both dermatomyositis and polymyositis. The investigator conducts comprehensive research into innovative therapeutic approaches for these rare inflammatory muscle conditions.
- Efgartigimod PH20 SC therapy
- IgPro20 subcutaneous treatment
- Brepocitinib clinical applications
Evaluates both short-term efficacy and long-term safety profiles of various therapeutic agents in adult patients with active IIM.
Advanced Therapeutics
Focuses on the development and evaluation of targeted immunomodulatory therapies. The investigator studies innovative treatment approaches including monoclonal antibodies and novel biological agents.
- Anifrolumab subcutaneous administration
- Dazukibart therapeutic applications
- Nipocalimab treatment protocols
Examines disease activity markers and treatment responses in inflammatory conditions.
Vascular Inflammation
Conducts research in giant cell arteritis (GCA) treatment modalities, specifically investigating the effectiveness of targeted therapies in combination with glucocorticoid management protocols.
- Secukinumab therapy evaluation
- Glucocorticoid taper strategies
- Sustained remission assessment
Studies innovative approaches to reduce reliance on long-term steroid therapy in vascular inflammation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.